全文获取类型
收费全文 | 5297篇 |
免费 | 376篇 |
国内免费 | 26篇 |
学科分类
医药卫生 | 5699篇 |
出版年
2021年 | 44篇 |
2020年 | 49篇 |
2019年 | 53篇 |
2018年 | 94篇 |
2017年 | 48篇 |
2016年 | 87篇 |
2015年 | 95篇 |
2014年 | 122篇 |
2013年 | 172篇 |
2012年 | 226篇 |
2011年 | 229篇 |
2010年 | 140篇 |
2009年 | 166篇 |
2008年 | 222篇 |
2007年 | 257篇 |
2006年 | 226篇 |
2005年 | 215篇 |
2004年 | 199篇 |
2003年 | 214篇 |
2002年 | 207篇 |
2001年 | 179篇 |
2000年 | 208篇 |
1999年 | 169篇 |
1998年 | 93篇 |
1997年 | 80篇 |
1996年 | 63篇 |
1995年 | 50篇 |
1994年 | 47篇 |
1993年 | 41篇 |
1992年 | 95篇 |
1991年 | 95篇 |
1990年 | 93篇 |
1989年 | 110篇 |
1988年 | 103篇 |
1987年 | 80篇 |
1986年 | 86篇 |
1985年 | 81篇 |
1984年 | 55篇 |
1983年 | 64篇 |
1981年 | 37篇 |
1980年 | 39篇 |
1979年 | 64篇 |
1978年 | 48篇 |
1977年 | 39篇 |
1975年 | 40篇 |
1974年 | 40篇 |
1973年 | 59篇 |
1972年 | 51篇 |
1970年 | 39篇 |
1969年 | 38篇 |
排序方式: 共有5699条查询结果,搜索用时 31 毫秒
61.
Lahousen T Hegenbarth K Ille R Lipp RW Krause R Little RR Schnedl WJ 《World journal of gastroenterology : WJG》2004,10(15):2284-2286
AIM: To evaluate the glycated hemoglobin (HbA(1c)) determination methods and to determine fructosamine in patients with chronic hepatitis, compensated cirrhosis and in patients with chronic hepatitis treated with ribavirin. METHODS: HbA(1c) values were determined in 15 patients with compensated liver cirrhosis and in 20 patients with chronic hepatitis using the ion-exchange high performance liquid chromatography and the immunoassay methods. Fructosamine was determined using nitroblue tetrazolium. RESULTS: Forty percent of patients with liver cirrhosis had HbA(1c) results below the non-diabetic reference range by at least one HbA(1c) method, while fructosamine results were either within the reference range or elevated. Twenty percent of patients with chronic hepatitis (hepatic fibrosis) had HbA(1c) results below the non-diabetic reference range by at least one HbA(1c) method. In patients with chronic hepatitis treated with ribavirin, 50% of HbA(1c) results were below the non-diabetic reference using at least one of the HbA(1c) methods. CONCLUSION: Only evaluated in context with all liver function parameters as well as a red blood count including reticulocytes, HbA(1c) results should be used in patients with advanced liver disease. HbA(1c) and fructosamine measurements should be used with caution when evaluating long-term glucose control in patients with hepatic cirrhosis or in patients with chronic hepatitis and ribavirin treatment. 相似文献
62.
63.
64.
Krause MS McClenaghan NH Flatt PR de Bittencourt PI Murphy C Newsholme P 《The Journal of endocrinology》2011,211(1):87-97
In this work, our aim was to determine whether L-arginine (a known insulinotropic amino acid) can promote a shift of β-cell intermediary metabolism favoring glutathione (GSH) and glutathione disulfide (GSSG) antioxidant responses, stimulus-secretion coupling and functional integrity. Clonal BRIN-BD11 β-cells and mouse islets were cultured for 24 h at various L-arginine concentrations (0-1.15 mmol/l) in the absence or presence of a proinflammatory cytokine cocktail (interleukin 1β, tumour necrosis factor α and interferon γ). Cells were assessed for viability, insulin secretion, GSH, GSSG, glutamate, nitric oxide (NO), superoxide, urea, lactate and for the consumption of glucose and glutamine. Protein levels of NO synthase-2, AMP-activated protein kinase (AMPK) and the heat shock protein 72 (HSP72) were also evaluated. We found that L-arginine at 1.15 mmol/l attenuated the loss of β-cell viability observed in the presence of proinflammatory cytokines. L-arginine increased total cellular GSH and glutamate levels but reduced the GSSG/GSH ratio and glutamate release. The amino acid stimulated glucose consumption in the presence of cytokines while also stimulating AMPK phosphorylation and HSP72 expression. Proinflammatory cytokines reduced, by at least 50%, chronic (24 h) insulin secretion, an effect partially attenuated by L-arginine. Acute insulin secretion was robustly stimulated by L-arginine but this effect was abolished in the presence of cytokines. We conclude that L-arginine can stimulate β-cell insulin secretion, antioxidant and protective responses, enabling increased functional integrity of β-cells and islets in the presence of proinflammatory cytokines. Glucose consumption and intermediary metabolism were increased by L-arginine. These results highlight the importance of L-arginine availability for β-cells during inflammatory challenge. 相似文献
65.
66.
67.
Lymphoguanylin: cloning and characterization of a unique member of the guanylin peptide family 总被引:3,自引:0,他引:3
Forte LR Eber SL Fan X London RM Wang Y Rowland LM Chin DT Freeman RH Krause WJ 《Endocrinology》1999,140(4):1800-1806
68.
Bone marrow transplantation for patients with Philadelphia chromosome- positive acute lymphoblastic leukemia 总被引:1,自引:2,他引:1
Forman SJ; O'Donnell MR; Nademanee AP; Snyder DS; Bierman PJ; Schmidt GM; Fahey JL; Stein AS; Parker PM; Blume KG 《Blood》1987,70(2):587-588
We report the treatment outcome of allogeneic bone marrow transplantation in ten patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Six patients are alive and well for 6 to 30 months (median 19 months) after transplantation. Four patients died with transplant related complications. In view of the poor prognosis associated with this disease, marrow ablation followed by allogeneic or syngeneic marrow grafting may be the preferred treatment modality if a suitable marrow donor is available. 相似文献
69.
Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation. 总被引:4,自引:2,他引:4 下载免费PDF全文
Y Takeda J E Krause 《Proceedings of the National Academy of Sciences of the United States of America》1989,86(1):392-396
Neuropeptide K (NPK) is an N-terminally extended derivative of neurokinin A (NKA) that can be a final product in the posttranslational processing of beta-preprotachykinin. A rat salivation bioassay was used to demonstrate potent effects of NPK at low doses, while effects due to NKA were much weaker at higher doses. The rank order of potency of beta-preprotachykinin-derived peptides on salivation responses was NPK greater than substance P greater than NKA much greater than beta-preprotachykinin-(72-96)-peptide. The time course of the NPK response was longer than that observed with substance P. The responses elicited by NPK were blocked by the tachykinin antagonist [D-Pro2,D-Trp7,9]substance P but not by atropine. In peptide coinfusion studies, NPK strikingly potentiated the salivation responses elicited by substance P. NPK in vitro displayed a 100 times lower potency than substance P in displacing 3H-labeled substance P binding in submandibular gland membranes, a tissue rich in SP-P type (NK-1) receptors. The possible cellular mechanisms by which NPK stimulates salivary gland secretion are discussed. We conclude that NPK and substance P may be cotransmitters derived by posttranslational processing of beta-preprotachykinin. 相似文献
70.
B. Zimmer G. Pallocca N. Dreser S. Foerster T. Waldmann J. Westerhout S. Julien K. H. Krause C. van Thriel J. G. Hengstler A. Sachinidis S. Bosgra M. Leist 《Archives of toxicology》2014,88(5):1109-1126
Developmental toxicity in vitro assays have hitherto been established as stand-alone systems, based on a limited number of toxicants. Within the embryonic stem cell-based novel alternative tests project, we developed a test battery framework that allows inclusion of any developmental toxicity assay and that explores the responses of such test systems to a wide range of drug-like compounds. We selected 28 compounds, including several biologics (e.g., erythropoietin), classical pharmaceuticals (e.g., roflumilast) and also six environmental toxicants. The chemical, toxicological and clinical data of this screen library were compiled. In order to determine a non-cytotoxic concentration range, cytotoxicity data were obtained for all compounds from HEK293 cells and from murine embryonic stem cells. Moreover, an estimate of relevant exposures was provided by literature data mining. To evaluate feasibility of the suggested test framework, we selected a well-characterized assay that evaluates ‘migration inhibition of neural crest cells.’ Screening at the highest non-cytotoxic concentration resulted in 11 hits (e.g., geldanamycin, abiraterone, gefitinib, chlorpromazine, cyproconazole, arsenite). These were confirmed in concentration–response studies. Subsequent pharmacokinetic modeling indicated that triadimefon exerted its effects at concentrations relevant to the in vivo situation, and also interferon-β and polybrominated diphenyl ether showed effects within the same order of magnitude of concentrations that may be reached in humans. In conclusion, the test battery framework can identify compounds that disturb processes relevant for human development and therefore may represent developmental toxicants. The open structure of the strategy allows rich information to be generated on both the underlying library, and on any contributing assay. 相似文献